FENTANYL

FENTANYL was reported 99071 times

FENTANYL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PRESBYACUSIS 144 0.4675
1 VAGINAL FLATULENCE 125 0.4125
2 INSPIRATORY CAPACITY DECREASED 103 0.3718
3 ANAESTHETIC COMPLICATION NEUROLOGICAL 312 0.3444
4 NEUROMUSCULAR BLOCK PROLONGED 111 0.3008
5 MYOGLOBIN URINE PRESENT 64 0.2602
6 VICTIM OF HOMICIDE 144 0.2474
7 MATERNAL EXPOSURE DURING DELIVERY 241 0.2432
8 DELAYED RECOVERY FROM ANAESTHESIA 208 0.2194
9 COUNTERFEIT PRODUCT ADMINISTERED 261 0.2002
10 AMNESTIC DISORDER 93 0.1910
11 DRUG DIVERSION 1175 0.1901
12 OPIATES POSITIVE 86 0.1792
13 PRODUCT COUNTERFEIT 305 0.1766
14 PLEURAL THICKENING 112 0.1637
15 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 62 0.1632
16 PLEURAL FIBROSIS 164 0.1609
17 HYPERTHERMIA MALIGNANT 236 0.1585
18 PROCEDURAL HYPOTENSION 122 0.1434
19 BLOOD MAGNESIUM INCREASED 125 0.1386
20 PROPOFOL INFUSION SYNDROME 95 0.1348
21 DRUG ABUSE 10851 0.1302
22 FOETAL EXPOSURE DURING DELIVERY 80 0.1180
23 HOMICIDE 207 0.1123
24 BRADYCARDIA FOETAL 92 0.1107
25 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 109 0.1026
26 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 631 0.1021
27 FEMALE GENITAL TRACT FISTULA 153 0.0895
28 ACCIDENTAL DEATH 154 0.0828
29 INADEQUATE ANALGESIA 661 0.0777
30 RESPIRATORY DEPRESSION 923 0.0752
31 OSTEOSCLEROSIS 115 0.0730
32 ANAESTHETIC COMPLICATION 193 0.0718
33 BONE CYST 67 0.0714
34 SEROTONIN SYNDROME 1337 0.0695
35 DRUG SPECIFIC ANTIBODY 95 0.0693
36 NON-CARDIOGENIC PULMONARY OEDEMA 72 0.0681
37 RADICULOPATHY 179 0.0679
38 SYSTEMIC INFECTION 111 0.0669
39 DEAFNESS NEUROSENSORY 208 0.0632
40 RESPIRATORY ACIDOSIS 244 0.0620
41 PROCTITIS 172 0.0613
42 STREPTOCOCCAL SEPSIS 68 0.0573
43 DRUG USE DISORDER 463 0.0550
44 BRADYPNOEA 146 0.0541
45 LABILE BLOOD PRESSURE 64 0.0539
46 LEARNING DISABILITY 283 0.0531
47 SUBSTANCE USE 82 0.0525
48 ALLODYNIA 60 0.0513
49 BREAKTHROUGH PAIN 115 0.0497
50 RESPIRATORY RATE DECREASED 155 0.0493
51 PSEUDOMONAL SEPSIS 86 0.0491
52 SUBSTANCE ABUSE 399 0.0490
53 CLONUS 134 0.0489
54 HYPERCAPNIA 146 0.0484
55 PULSELESS ELECTRICAL ACTIVITY 198 0.0473
56 HYPOVENTILATION 154 0.0472
57 APNOEA 367 0.0471
58 KOUNIS SYNDROME 105 0.0462
59 SEDATION COMPLICATION 117 0.0458
60 VASOPLEGIA SYNDROME 74 0.0451
61 DRUG TOLERANCE 227 0.0448
62 RESPIRATORY ARREST 1234 0.0447
63 MIOSIS 358 0.0446
64 HYPERAESTHESIA 358 0.0435
65 CANCER PAIN 109 0.0426
66 LARYNGOSPASM 114 0.0423
67 SUBSTANCE USE DISORDER 135 0.0423
68 DIABETES INSIPIDUS 101 0.0419
69 CARDIO-RESPIRATORY ARREST 1713 0.0409
70 EPIGASTRIC DISCOMFORT 160 0.0409
71 HYPERPARATHYROIDISM SECONDARY 100 0.0399
72 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 104 0.0397
73 UNRESPONSIVE TO STIMULI 1007 0.0390
74 DRUG SCREEN POSITIVE 308 0.0389
75 WHITE BLOOD CELL COUNT ABNORMAL 244 0.0382
76 DRUG DEPENDENCE 6127 0.0381
77 NEPHROGENIC ANAEMIA 174 0.0375
78 RESUSCITATION 61 0.0368
79 METHAEMOGLOBINAEMIA 85 0.0367
80 STRESS CARDIOMYOPATHY 213 0.0366
81 TOXICITY TO VARIOUS AGENTS 6105 0.0362
82 DRUG EFFECT INCREASED 112 0.0354
83 STRIDOR 103 0.0350
84 DRUG WITHDRAWAL SYNDROME 3047 0.0347
85 MYOCLONUS 413 0.0346
86 ENDOTRACHEAL INTUBATION 95 0.0339
87 COMA SCALE ABNORMAL 95 0.0328
88 CHRONIC SINUSITIS 123 0.0327
89 PRODUCT ADHESION ISSUE 1126 0.0315
90 HAEMODYNAMIC INSTABILITY 240 0.0315
91 DRUG WITHDRAWAL SYNDROME NEONATAL 453 0.0306
92 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 517 0.0301
93 PARAPLEGIA 87 0.0301
94 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 65 0.0296
95 EXPOSURE TO TOXIC AGENT 94 0.0294
96 BRAIN OEDEMA 368 0.0291
97 MULTI-ORGAN FAILURE 496 0.0287
98 DEVELOPMENTAL DELAY 258 0.0286
99 BRAIN DEATH 88 0.0285
100 AORTIC ARTERIOSCLEROSIS 72 0.0280
101 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 92 0.0278
102 CARDIAC ARREST 2289 0.0277
103 OVERDOSE 5902 0.0273
104 TOXIC ENCEPHALOPATHY 137 0.0270
105 HYPERREFLEXIA 94 0.0270
106 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 112 0.0269
107 ENDOMETRIOSIS 127 0.0266
108 DEVICE ADHESION ISSUE 405 0.0264
109 CACHEXIA 135 0.0262
110 BRONCHOSPASM 369 0.0258
111 INCREASED BRONCHIAL SECRETION 66 0.0258
112 ATRIOVENTRICULAR BLOCK SECOND DEGREE 78 0.0257
113 HYPOXIA 899 0.0255
114 ATELECTASIS 243 0.0251
115 WITHDRAWAL SYNDROME 1045 0.0249
116 HYPOPNOEA 85 0.0245
117 TACHYARRHYTHMIA 61 0.0244
118 PATHOLOGICAL FRACTURE 124 0.0244
119 ARTERIOSPASM CORONARY 98 0.0244
120 EMOTIONAL DISTRESS 2947 0.0243
121 BRAIN INJURY 238 0.0237
122 AMYLASE INCREASED 87 0.0236
123 PULSE ABSENT 112 0.0235
124 ANAPHYLACTIC REACTION 1299 0.0235
125 DRUG TOXICITY 320 0.0235
126 DEPRESSED LEVEL OF CONSCIOUSNESS 911 0.0230
127 MUSCLE RIGIDITY 275 0.0230
128 AREFLEXIA 61 0.0228
129 DISABILITY 448 0.0226
130 AUTONOMIC NERVOUS SYSTEM IMBALANCE 66 0.0226
131 FEAR 606 0.0225
132 SPINAL CORD COMPRESSION 87 0.0223
133 DELIRIUM 775 0.0223
134 FAECALOMA 121 0.0221
135 BRADYCARDIA 1169 0.0220
136 TACHYPNOEA 299 0.0220
137 PROSTATE CANCER METASTATIC 73 0.0218
138 LEUKOENCEPHALOPATHY 81 0.0217
139 METABOLIC ENCEPHALOPATHY 65 0.0216
140 IMPAIRED DRIVING ABILITY 243 0.0214
141 VENTRICULAR TACHYCARDIA 352 0.0213
142 POST PROCEDURAL COMPLICATION 404 0.0210
143 SINUS BRADYCARDIA 203 0.0210
144 STUPOR 67 0.0208
145 DRUG ABUSER 126 0.0205
146 WOUND DEHISCENCE 69 0.0204
147 MULTIPLE DRUG OVERDOSE 101 0.0203
148 BRAIN HERNIATION 60 0.0201
149 ACUTE PULMONARY OEDEMA 112 0.0199
150 METASTASES TO SPINE 67 0.0199
151 SINUS TACHYCARDIA 283 0.0199
152 ACIDOSIS 152 0.0199
153 LEFT VENTRICULAR HYPERTROPHY 85 0.0198
154 PROCEDURAL COMPLICATION 151 0.0197
155 CIRCULATORY COLLAPSE 334 0.0196
156 RENAL INJURY 581 0.0195
157 POST-TRAUMATIC STRESS DISORDER 131 0.0195
158 VENTRICULAR FIBRILLATION 213 0.0192
159 BONE LESION 69 0.0191
160 HYPERTHERMIA 146 0.0191
161 ANHEDONIA 501 0.0190
162 ACUTE RESPIRATORY FAILURE 365 0.0190
163 TORSADE DE POINTES 148 0.0188
164 PREMATURE DELIVERY 297 0.0186
165 ACCIDENTAL OVERDOSE 681 0.0186
166 OSTEOPENIA 282 0.0186
167 DIVERTICULUM INTESTINAL 81 0.0185
168 HYPOVOLAEMIA 108 0.0184
169 POISONING 231 0.0184
170 VASCULAR DEVICE INFECTION 83 0.0183
171 MENTAL STATUS CHANGES 508 0.0183
172 PULMONARY ALVEOLAR HAEMORRHAGE 101 0.0180
173 DRUG INTERACTION 2847 0.0179
174 OXYGEN SATURATION DECREASED 1005 0.0179
175 BLOOD POTASSIUM INCREASED 289 0.0178
176 RESPIRATORY FAILURE 1297 0.0178
177 PULMONARY OEDEMA 795 0.0177
178 PULMONARY CONGESTION 234 0.0177
179 METABOLIC ACIDOSIS 562 0.0176
180 ARTERIOSCLEROSIS CORONARY ARTERY 116 0.0175
181 VENTRICULAR ARRHYTHMIA 64 0.0175
182 TROPONIN INCREASED 133 0.0175
183 ENCEPHALOPATHY 427 0.0174
184 PERFORMANCE STATUS DECREASED 81 0.0173
185 ORAL CANDIDIASIS 228 0.0173
186 ACUTE RESPIRATORY DISTRESS SYNDROME 306 0.0173
187 CYANOSIS 272 0.0173
188 SEDATION 452 0.0172
189 NORMAL NEWBORN 93 0.0171
190 PROCTALGIA 110 0.0171
191 LUNG INFILTRATION 151 0.0171
192 INTESTINAL ISCHAEMIA 94 0.0171
193 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 116 0.0170
194 STATUS EPILEPTICUS 192 0.0170
195 TRICUSPID VALVE INCOMPETENCE 133 0.0167
196 ANAPHYLACTIC SHOCK 428 0.0166
197 PNEUMONIA ASPIRATION 411 0.0164
198 ATRIOVENTRICULAR BLOCK COMPLETE 110 0.0164
199 HYPOTHERMIA 166 0.0164
200 INJURY 1144 0.0163
201 BLOOD ALBUMIN DECREASED 129 0.0162
202 DECUBITUS ULCER 132 0.0162
203 SUPRAVENTRICULAR TACHYCARDIA 155 0.0162
204 METASTASES TO LYMPH NODES 109 0.0161
205 METASTASES TO BONE 264 0.0161
206 CARDIOGENIC SHOCK 228 0.0159
207 MONOPLEGIA 69 0.0159
208 MALNUTRITION 177 0.0158
209 ANAPHYLACTOID REACTION 65 0.0158
210 CYST 196 0.0158
211 MYDRIASIS 202 0.0157
212 SPINAL OSTEOARTHRITIS 138 0.0157
213 HYPERNATRAEMIA 78 0.0156
214 SENSITIVITY TO WEATHER CHANGE 82 0.0156
215 COMA 736 0.0154
216 COAGULOPATHY 257 0.0154
217 BLOOD PRESSURE SYSTOLIC DECREASED 70 0.0154
218 PREMATURE BABY 460 0.0153
219 HYPOTENSION 3062 0.0152
220 NYSTAGMUS 81 0.0152
221 INTENTIONAL DRUG MISUSE 319 0.0152
222 ASPIRATION 167 0.0152
223 OSTEOMYELITIS 276 0.0152
224 ILEUS PARALYTIC 68 0.0152
225 EUPHORIC MOOD 156 0.0152
226 DENTAL CARIES 168 0.0152
227 BLOOD LACTIC ACID INCREASED 80 0.0152
228 SCOLIOSIS 93 0.0150
229 URINARY RETENTION 498 0.0149
230 LOW BIRTH WEIGHT BABY 118 0.0148
231 MITRAL VALVE INCOMPETENCE 168 0.0148
232 FAILURE TO THRIVE 77 0.0148
233 VENTRICULAR EXTRASYSTOLES 154 0.0148
234 INTERVERTEBRAL DISC DEGENERATION 137 0.0148
235 APPLICATION SITE VESICLES 96 0.0148
236 LEFT VENTRICULAR DYSFUNCTION 99 0.0148
237 COMPRESSION FRACTURE 79 0.0147
238 IRON DEFICIENCY 66 0.0147
239 NEUROTOXICITY 257 0.0147
240 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 74 0.0146
241 MULTIPLE ORGAN DYSFUNCTION SYNDROME 414 0.0146
242 COMPLETED SUICIDE 1216 0.0146
243 MYOCARDIAL ISCHAEMIA 166 0.0146
244 BUNDLE BRANCH BLOCK LEFT 61 0.0144
245 GENERALISED TONIC-CLONIC SEIZURE 238 0.0144
246 CEREBRAL ISCHAEMIA 74 0.0144
247 DYSPHEMIA 63 0.0144
248 ILEUS 178 0.0143
249 NEUROLEPTIC MALIGNANT SYNDROME 169 0.0142
250 INCOHERENT 92 0.0142
251 RESPIRATORY DISTRESS 392 0.0142
252 DISSEMINATED INTRAVASCULAR COAGULATION 199 0.0141
253 VARICOSE VEIN 73 0.0141
254 EXOSTOSIS 129 0.0141
255 VAGINAL DISCHARGE 142 0.0140
256 WRONG TECHNIQUE IN DRUG USAGE PROCESS 509 0.0140
257 HEPARIN-INDUCED THROMBOCYTOPENIA 69 0.0140
258 APPLICATION SITE RASH 192 0.0139
259 LIVE BIRTH 116 0.0139
260 TACHYCARDIA 1230 0.0138
261 HYPOVOLAEMIC SHOCK 65 0.0136
262 CARDIOMEGALY 166 0.0135
263 UNEVALUABLE EVENT 1021 0.0135
264 RENAL FAILURE 1789 0.0135
265 END STAGE RENAL DISEASE 245 0.0134
266 BODY TEMPERATURE DECREASED 130 0.0132
267 RESTLESSNESS 482 0.0132
268 ACCIDENT 157 0.0131
269 TOXIC EPIDERMAL NECROLYSIS 199 0.0131
270 DRUG LEVEL ABOVE THERAPEUTIC 60 0.0131
271 PNEUMOTHORAX 207 0.0130
272 URINE OUTPUT DECREASED 114 0.0130
273 DISORIENTATION 516 0.0130
274 APLASTIC ANAEMIA 68 0.0130
275 AGITATION 951 0.0129
276 RENAL TUBULAR NECROSIS 127 0.0129
277 BEHAVIOUR DISORDER 70 0.0129
278 FOETAL EXPOSURE DURING PREGNANCY 1036 0.0127
279 METASTASES TO LUNG 147 0.0127
280 INFLAMMATORY MARKER INCREASED 63 0.0127
281 GASTROINTESTINAL MOTILITY DISORDER 68 0.0127
282 ALTERED STATE OF CONSCIOUSNESS 274 0.0126
283 HYPERKALAEMIA 443 0.0126
284 HYPOALBUMINAEMIA 98 0.0126
285 LEUKOCYTOSIS 228 0.0126
286 HYPERCALCAEMIA 155 0.0125
287 HAEMATEMESIS 318 0.0125
288 KLEBSIELLA INFECTION 63 0.0124
289 DRUG ADMINISTRATION ERROR 381 0.0124
290 PULMONARY HAEMORRHAGE 97 0.0124
291 NECROSIS 69 0.0124
292 CARDIOMYOPATHY 182 0.0123
293 RENAL IMPAIRMENT 1027 0.0122
294 SEPTIC SHOCK 531 0.0122
295 DEFORMITY 113 0.0121
296 MOTOR DYSFUNCTION 123 0.0121
297 RHABDOMYOLYSIS 503 0.0120
298 HYPOTONIA 120 0.0120
299 ECCHYMOSIS 82 0.0119
300 PAIN 7330 0.0119
301 INCONTINENCE 126 0.0119
302 PARALYSIS 170 0.0119
303 ACUTE KIDNEY INJURY 1814 0.0118
304 GENERAL PHYSICAL HEALTH DETERIORATION 1364 0.0118
305 NEUTROPENIC SEPSIS 84 0.0117
306 SMALL INTESTINAL OBSTRUCTION 144 0.0117
307 DRUG LEVEL INCREASED 193 0.0116
308 INTERVERTEBRAL DISC PROTRUSION 254 0.0116
309 MENTAL DISORDER 505 0.0116
310 OLIGURIA 72 0.0116
311 HIATUS HERNIA 150 0.0116
312 RENAL FAILURE CHRONIC 89 0.0116
313 PELVIC FRACTURE 90 0.0115
314 THERMAL BURN 82 0.0115
315 GENERAL PHYSICAL CONDITION ABNORMAL 78 0.0115
316 ARTERIOSCLEROSIS 108 0.0115
317 CONTRAINDICATED PRODUCT ADMINISTERED 346 0.0114
318 SOCIAL AVOIDANT BEHAVIOUR 66 0.0114
319 ROAD TRAFFIC ACCIDENT 476 0.0114
320 MAJOR DEPRESSION 83 0.0113
321 RENAL FAILURE ACUTE 480 0.0113
322 ESCHERICHIA INFECTION 93 0.0113
323 PROTHROMBIN TIME PROLONGED 67 0.0112
324 SEPSIS 1249 0.0112
325 METABOLIC DISORDER 65 0.0112
326 PHARMACEUTICAL PRODUCT COMPLAINT 290 0.0112
327 BACTERAEMIA 132 0.0111
328 BLOOD PRESSURE DECREASED 738 0.0111
329 QUALITY OF LIFE DECREASED 149 0.0111
330 POSTOPERATIVE WOUND INFECTION 75 0.0111
331 TOOTH LOSS 230 0.0111
332 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 98 0.0111
333 POST PROCEDURAL HAEMORRHAGE 129 0.0111
334 BLOOD LACTATE DEHYDROGENASE INCREASED 175 0.0110
335 DRUG PRESCRIBING ERROR 212 0.0110
336 PARAESTHESIA ORAL 159 0.0110
337 COLITIS 417 0.0110
338 OSTEOARTHRITIS 466 0.0110
339 CONFUSIONAL STATE 1771 0.0109
340 FEELING OF BODY TEMPERATURE CHANGE 64 0.0109
341 DUODENAL ULCER 77 0.0109
342 HYPOKALAEMIA 503 0.0109
343 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 104 0.0109
344 MATERNAL EXPOSURE DURING PREGNANCY 968 0.0108
345 BLOOD PRESSURE DIASTOLIC DECREASED 80 0.0108
346 CHRONIC KIDNEY DISEASE 823 0.0108
347 SOMNOLENCE 2169 0.0108
348 HAEMORRHOIDS 210 0.0108
349 ASCITES 316 0.0107
350 HEPATIC FAILURE 324 0.0107
351 UROSEPSIS 99 0.0107
352 METASTASES TO CENTRAL NERVOUS SYSTEM 138 0.0107
353 SENSORY LOSS 86 0.0107
354 BODY TEMPERATURE INCREASED 217 0.0106
355 SKIN LESION 291 0.0106
356 HYPERHIDROSIS 1358 0.0105
357 PULMONARY HYPERTENSION 219 0.0105
358 BEDRIDDEN 138 0.0105
359 PRODUCT PRESCRIBING ERROR 250 0.0105
360 HEPATOMEGALY 103 0.0105
361 ELECTROLYTE IMBALANCE 121 0.0104
362 SPINAL COMPRESSION FRACTURE 86 0.0104
363 APPLICATION SITE PRURITUS 236 0.0104
364 ANKYLOSING SPONDYLITIS 137 0.0104
365 ODYNOPHAGIA 62 0.0104
366 APPLICATION SITE REACTION 73 0.0104
367 PLEURAL EFFUSION 629 0.0103
368 TERMINAL STATE 69 0.0103
369 ELECTROCARDIOGRAM QT PROLONGED 370 0.0103
370 NEURALGIA 250 0.0103
371 HYPERBILIRUBINAEMIA 106 0.0102
372 SLEEP APNOEA SYNDROME 195 0.0102
373 JOINT DISLOCATION 108 0.0102
374 BLOOD MAGNESIUM DECREASED 88 0.0102
375 ELECTROCARDIOGRAM ABNORMAL 80 0.0102
376 SHOCK HAEMORRHAGIC 83 0.0102
377 ASPHYXIA 83 0.0102
378 HEPATITIS ACUTE 66 0.0101
379 COLITIS ISCHAEMIC 68 0.0101
380 DRUG ADMINISTERED AT INAPPROPRIATE SITE 106 0.0100
381 FLANK PAIN 94 0.0100
382 HYDRONEPHROSIS 75 0.0100
383 LOSS OF CONSCIOUSNESS 1281 0.0100
384 APPLICATION SITE ERYTHEMA 262 0.0100
385 DYSARTHRIA 375 0.0100
386 BLOOD CALCIUM DECREASED 112 0.0100
387 SPINAL PAIN 116 0.0099
388 TOOTH FRACTURE 109 0.0099
389 MACULAR DEGENERATION 118 0.0099
390 ANURIA 85 0.0099
391 DEPENDENCE 538 0.0098
392 INTENTIONAL PRODUCT MISUSE 855 0.0098
393 HAEMODIALYSIS 82 0.0098
394 NO THERAPEUTIC RESPONSE 119 0.0097
395 MUSCULOSKELETAL CHEST PAIN 151 0.0097
396 DRUG EFFECT DECREASED 525 0.0097
397 OBSTRUCTIVE AIRWAYS DISORDER 108 0.0097
398 SHOCK 222 0.0096
399 ATRIAL FLUTTER 77 0.0096
400 DYSTONIA 187 0.0096
401 PARANOIA 166 0.0096
402 NERVE INJURY 107 0.0096
403 SCREAMING 61 0.0096
404 FEBRILE NEUTROPENIA 635 0.0096
405 RENAL CYST 76 0.0096
406 COVID-19 PNEUMONIA 112 0.0095
407 APPLICATION SITE IRRITATION 118 0.0095
408 EXPOSURE DURING PREGNANCY 589 0.0095
409 HYPOCALCAEMIA 179 0.0094
410 HYPERSOMNIA 271 0.0094
411 INTESTINAL PERFORATION 106 0.0094
412 ACUTE HEPATIC FAILURE 129 0.0094
413 DIVERTICULUM 67 0.0094
414 ULCER 150 0.0094
415 CANDIDA INFECTION 159 0.0094
416 RESTLESS LEGS SYNDROME 171 0.0094
417 MUCOSAL INFLAMMATION 246 0.0094
418 MUSCLE TWITCHING 216 0.0094
419 ANAL INCONTINENCE 84 0.0093
420 BLOOD CREATINE PHOSPHOKINASE INCREASED 268 0.0093
421 MALIGNANT NEOPLASM PROGRESSION 951 0.0093
422 BLOOD UREA INCREASED 155 0.0092
423 RIB FRACTURE 190 0.0092
424 DYSKINESIA 375 0.0092
425 GROIN PAIN 81 0.0092
426 LIVER FUNCTION TEST INCREASED 198 0.0092
427 LETHARGY 530 0.0092
428 TUMOUR LYSIS SYNDROME 81 0.0092
429 ANAEMIA 1749 0.0092
430 FREQUENT BOWEL MOVEMENTS 247 0.0091
431 CONSTIPATION 1994 0.0091
432 RESPIRATION ABNORMAL 63 0.0091
433 DEHYDRATION 1219 0.0091
434 SPINAL FRACTURE 183 0.0091
435 TOOTH ABSCESS 93 0.0091
436 SUBARACHNOID HAEMORRHAGE 93 0.0091
437 RESPIRATORY RATE INCREASED 81 0.0091
438 PLASMA CELL MYELOMA 355 0.0091
439 GRAND MAL CONVULSION 84 0.0091
440 PSYCHOLOGICAL TRAUMA 78 0.0090
441 POLYNEUROPATHY 108 0.0090
442 CAESAREAN SECTION 105 0.0090
443 HEPATIC ENCEPHALOPATHY 84 0.0090
444 EYE MOVEMENT DISORDER 61 0.0089
445 HYPOMAGNESAEMIA 124 0.0089
446 ADRENAL INSUFFICIENCY 108 0.0089
447 CLOSTRIDIUM DIFFICILE COLITIS 94 0.0089
448 PRODUCT QUALITY ISSUE 1204 0.0089
449 DERMATITIS CONTACT 101 0.0088
450 LYMPHOEDEMA 61 0.0088
451 IMPAIRED GASTRIC EMPTYING 120 0.0088
452 MUSCULOSKELETAL PAIN 460 0.0088
453 BLOOD ALKALINE PHOSPHATASE INCREASED 218 0.0088
454 HAEMATOCRIT DECREASED 174 0.0088
455 BACK INJURY 95 0.0087
456 PULMONARY MASS 130 0.0087
457 HEPATIC STEATOSIS 162 0.0087
458 NEUTROPHIL COUNT INCREASED 89 0.0087
459 ANXIETY 2466 0.0087
460 BLOOD CREATININE INCREASED 565 0.0086
461 HYPERGLYCAEMIA 315 0.0086
462 MENTAL IMPAIRMENT 208 0.0086
463 C-REACTIVE PROTEIN INCREASED 312 0.0086
464 METASTASES TO LIVER 150 0.0085
465 EMPHYSEMA 86 0.0085
466 HYPOPHOSPHATAEMIA 63 0.0085
467 ASPARTATE AMINOTRANSFERASE INCREASED 449 0.0084
468 SPINAL DISORDER 80 0.0084
469 ATAXIA 100 0.0084
470 CELLULITIS 423 0.0084
471 UPPER GASTROINTESTINAL HAEMORRHAGE 141 0.0084
472 BLOOD BILIRUBIN INCREASED 226 0.0084
473 OESOPHAGITIS 91 0.0083
474 HALLUCINATION 627 0.0083
475 HEART RATE DECREASED 292 0.0083
476 WOUND INFECTION 91 0.0083
477 ACUTE MYOCARDIAL INFARCTION 245 0.0083
478 GINGIVAL PAIN 66 0.0083
479 ALANINE AMINOTRANSFERASE INCREASED 508 0.0083
480 TENDERNESS 86 0.0082
481 TOOTHACHE 149 0.0082
482 BODY HEIGHT DECREASED 88 0.0082
483 HYPONATRAEMIA 462 0.0082
484 HYPERTENSIVE CRISIS 91 0.0082
485 BONE DISORDER 149 0.0082
486 HYPOPHAGIA 209 0.0082
487 EJECTION FRACTION DECREASED 127 0.0082
488 OSTEONECROSIS OF JAW 202 0.0082
489 MYOCARDITIS 93 0.0081
490 COLD SWEAT 143 0.0081
491 DEEP VEIN THROMBOSIS 527 0.0081
492 COORDINATION ABNORMAL 113 0.0081
493 MEDICATION ERROR 450 0.0081
494 GASTRITIS 213 0.0081
495 LIPASE INCREASED 62 0.0081
496 SKIN ULCER 209 0.0081
497 VOMITING 3799 0.0081
498 PERSONALITY CHANGE 75 0.0081
499 PRODUCT PRESCRIBING ISSUE 175 0.0080
500 PANCYTOPENIA 448 0.0080
501 THROMBOCYTOPENIA 894 0.0080
502 AMNESIA 519 0.0080
503 CYTOKINE RELEASE SYNDROME 160 0.0080
504 SENSORY DISTURBANCE 128 0.0080
505 HAEMATOCHEZIA 439 0.0079
506 RECTAL HAEMORRHAGE 341 0.0079
507 PSEUDOMONAS INFECTION 68 0.0079
508 ATRIOVENTRICULAR BLOCK 61 0.0079
509 BLOOD PRESSURE SYSTOLIC INCREASED 153 0.0078
510 POOR VENOUS ACCESS 81 0.0078
511 MASS 109 0.0078
512 FEELING COLD 217 0.0078
513 ABDOMINAL PAIN 1811 0.0078
514 RESPIRATORY DISORDER 232 0.0077
515 EATING DISORDER 165 0.0077
516 MUSCLE ATROPHY 98 0.0077
517 DEVICE RELATED INFECTION 119 0.0077
518 PRODUCT PACKAGING ISSUE 73 0.0077
519 GAMMA-GLUTAMYLTRANSFERASE INCREASED 170 0.0077
520 DEPRESSION 1742 0.0076
521 BACK PAIN 1778 0.0076
522 LIVER FUNCTION TEST ABNORMAL 222 0.0076
523 TUBULOINTERSTITIAL NEPHRITIS 143 0.0076
524 BURSITIS 92 0.0076
525 PERICARDIAL EFFUSION 175 0.0076
526 APHASIA 226 0.0075
527 IMPAIRED HEALING 245 0.0075
528 HAEMATURIA 255 0.0074
529 HALLUCINATION, VISUAL 157 0.0074
530 COGNITIVE DISORDER 347 0.0074
531 NERVOUS SYSTEM DISORDER 231 0.0074
532 PETECHIAE 77 0.0074
533 CLOSTRIDIUM DIFFICILE INFECTION 161 0.0074
534 HEPATIC CYTOLYSIS 94 0.0074
535 HEPATITIS C 89 0.0074
536 DEVICE MALFUNCTION 516 0.0073
537 ATRIAL FIBRILLATION 713 0.0073
538 SCIATICA 116 0.0073
539 IMPAIRED WORK ABILITY 155 0.0072
540 SCAR 124 0.0072
541 FIBROMYALGIA 176 0.0072
542 AGGRESSION 360 0.0072
543 NEOPLASM PROGRESSION 250 0.0072
544 SKIN LACERATION 78 0.0072
545 PSYCHOMOTOR HYPERACTIVITY 119 0.0072
546 BONE PAIN 420 0.0072
547 MUSCULOSKELETAL STIFFNESS 627 0.0071
548 GASTRIC ULCER 136 0.0071
549 SECRETION DISCHARGE 89 0.0071
550 NECK PAIN 397 0.0071
551 HAEMATOMA 184 0.0071
552 PROCEDURAL PAIN 197 0.0071
553 DELUSION 110 0.0071
554 PRESCRIBED OVERDOSE 137 0.0071
555 DYSPHAGIA 669 0.0070
556 LACTIC ACIDOSIS 228 0.0070
557 CORONARY ARTERY DISEASE 213 0.0070
558 PAIN IN JAW 199 0.0070
559 STEVENS-JOHNSON SYNDROME 156 0.0070
560 HOSPICE CARE 69 0.0070
561 BREAST CANCER METASTATIC 75 0.0070
562 MOVEMENT DISORDER 224 0.0070
563 ABNORMAL BEHAVIOUR 276 0.0070
564 ABSCESS 111 0.0070
565 URINARY INCONTINENCE 206 0.0069
566 PNEUMONIA 2250 0.0069
567 HYPERLIPIDAEMIA 83 0.0069
568 ROTATOR CUFF SYNDROME 89 0.0069
569 SCRATCH 73 0.0069
570 BLOOD PRESSURE FLUCTUATION 166 0.0069
571 STAPHYLOCOCCAL INFECTION 228 0.0069
572 OROPHARYNGEAL DISCOMFORT 62 0.0069
573 STOMATITIS 415 0.0068
574 PANIC ATTACK 249 0.0068
575 BLOOD POTASSIUM DECREASED 205 0.0068
576 FLUID OVERLOAD 99 0.0068
577 MUSCLE TIGHTNESS 110 0.0068
578 NEPHROPATHY TOXIC 76 0.0068
579 CHOLESTASIS 130 0.0068
580 PULMONARY EMBOLISM 643 0.0068
581 INCORRECT ROUTE OF DRUG ADMINISTRATION 241 0.0067
582 PYREXIA 2320 0.0067
583 LACERATION 63 0.0067
584 PNEUMONITIS 182 0.0067
585 DECREASED ACTIVITY 72 0.0067
586 HAEMOPTYSIS 186 0.0067
587 ECONOMIC PROBLEM 101 0.0067
588 HYPERTENSION 1410 0.0066
589 ORAL PAIN 149 0.0066
590 PALLOR 181 0.0066
591 SOPOR 88 0.0066
592 CHOLECYSTITIS 79 0.0066
593 HAEMOGLOBIN DECREASED 679 0.0066
594 NIGHT SWEATS 213 0.0066
595 IRON DEFICIENCY ANAEMIA 61 0.0066
596 DRUG LEVEL DECREASED 67 0.0066
597 OEDEMA PERIPHERAL 801 0.0066
598 SUBDURAL HAEMATOMA 94 0.0066
599 NAUSEA 5197 0.0066
600 HEMIPARESIS 111 0.0065
601 SUICIDE ATTEMPT 397 0.0065
602 DYSURIA 241 0.0065
603 HYPOKINESIA 95 0.0065
604 BIPOLAR DISORDER 71 0.0065
605 WHITE BLOOD CELL COUNT INCREASED 250 0.0065
606 LYMPHOCYTE COUNT DECREASED 115 0.0065
607 DECREASED APPETITE 1511 0.0065
608 LUNG INFECTION 101 0.0065
609 SPLENOMEGALY 76 0.0065
610 WEIGHT DECREASED 1809 0.0065
611 HEAD INJURY 205 0.0065
612 LIGAMENT SPRAIN 64 0.0065
613 KIDNEY INFECTION 127 0.0065
614 GENERALISED OEDEMA 80 0.0065
615 PLATELET COUNT INCREASED 84 0.0064
616 ARRHYTHMIA 304 0.0064
617 BLOOD SODIUM DECREASED 121 0.0064
618 TREMOR 1065 0.0064
619 DEATH 5522 0.0064
620 JAUNDICE 172 0.0064
621 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 307 0.0064
622 PELVIC PAIN 116 0.0064
623 CHILLS 748 0.0064
624 IMPAIRED QUALITY OF LIFE 91 0.0063
625 INTESTINAL OBSTRUCTION 238 0.0063
626 OEDEMA 342 0.0063
627 HEPATOCELLULAR INJURY 89 0.0063
628 OBESITY 100 0.0063
629 PNEUMOCYSTIS JIROVECII PNEUMONIA 63 0.0063
630 TOOTH DISORDER 139 0.0062
631 DEVICE FAILURE 95 0.0062
632 INTENTIONAL PRODUCT USE ISSUE 545 0.0062
633 BACK DISORDER 101 0.0062
634 HEART RATE INCREASED 615 0.0062
635 DISEASE PROGRESSION 734 0.0062
636 DRUG INTOLERANCE 599 0.0062
637 HEPATOTOXICITY 138 0.0062
638 WRIST FRACTURE 74 0.0062
639 COLITIS ULCERATIVE 275 0.0061
640 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 158 0.0061
641 WOUND 171 0.0061
642 SLEEP DISORDER 431 0.0061
643 DRY EYE 304 0.0061
644 SPINAL OPERATION 75 0.0061
645 DISTURBANCE IN ATTENTION 327 0.0061
646 APPLICATION SITE PAIN 133 0.0060
647 MIGRAINE 576 0.0060
648 PLATELET COUNT DECREASED 642 0.0060
649 THINKING ABNORMAL 112 0.0060
650 TOOTH INFECTION 79 0.0060
651 DIVERTICULITIS 166 0.0060
652 FALL 1991 0.0060
653 RED BLOOD CELL COUNT DECREASED 171 0.0060
654 GAIT DISTURBANCE 1143 0.0060
655 INTERNATIONAL NORMALISED RATIO INCREASED 170 0.0060
656 HYPOTHYROIDISM 190 0.0059
657 INFECTION 861 0.0059
658 LIVER INJURY 146 0.0059
659 URINARY TRACT INFECTION 1010 0.0059
660 FEEDING DISORDER 120 0.0059
661 MOBILITY DECREASED 424 0.0059
662 MYELODYSPLASTIC SYNDROME 85 0.0059
663 HYPOGLYCAEMIA 285 0.0059
664 GASTROINTESTINAL HAEMORRHAGE 490 0.0059
665 GLOMERULAR FILTRATION RATE DECREASED 72 0.0059
666 CONVULSION 335 0.0059
667 MUSCULAR WEAKNESS 661 0.0058
668 INSOMNIA 1545 0.0058
669 NEUTROPHIL COUNT DECREASED 236 0.0058
670 ASTHENIA 2171 0.0058
671 SKIN REACTION 81 0.0057
672 ARTHRITIS 451 0.0057
673 INTENTIONAL OVERDOSE 367 0.0057
674 DIALYSIS 81 0.0057
675 CHEST PAIN 1057 0.0057
676 PROSTATIC SPECIFIC ANTIGEN INCREASED 78 0.0057
677 ABASIA 139 0.0056
678 PERIPHERAL COLDNESS 77 0.0056
679 SUICIDAL IDEATION 513 0.0056
680 SEIZURE 646 0.0056
681 NEUROPATHY PERIPHERAL 531 0.0056
682 PULMONARY FIBROSIS 107 0.0056
683 CHOLELITHIASIS 182 0.0055
684 HIP FRACTURE 178 0.0055
685 RETCHING 118 0.0055
686 NEUTROPENIA 750 0.0055
687 FULL BLOOD COUNT DECREASED 111 0.0055
688 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 287 0.0055
689 HEPATIC FUNCTION ABNORMAL 202 0.0054
690 MOUTH ULCERATION 114 0.0054
691 DYSPNOEA 3060 0.0054
692 BLOOD IRON DECREASED 64 0.0054
693 SPEECH DISORDER 282 0.0054
694 FOOT FRACTURE 102 0.0054
695 OSTEOPOROSIS 221 0.0054
696 ANGIOEDEMA 237 0.0054
697 THERAPY NON-RESPONDER 240 0.0053
698 LEUKOPENIA 267 0.0053
699 LOCAL SWELLING 93 0.0053
700 GASTROOESOPHAGEAL REFLUX DISEASE 429 0.0053
701 PSYCHOTIC DISORDER 157 0.0053
702 TENDONITIS 82 0.0053
703 MUSCULOSKELETAL DISCOMFORT 91 0.0053
704 BLOOD PRESSURE ABNORMAL 105 0.0053
705 GASTROENTERITIS 77 0.0053
706 ABDOMINAL DISTENSION 550 0.0053
707 GAIT INABILITY 176 0.0053
708 DRY MOUTH 426 0.0052
709 HEPATITIS 134 0.0052
710 RESPIRATORY TRACT INFECTION 136 0.0052
711 HYPOAESTHESIA 781 0.0052
712 NODULE 68 0.0052
713 THERAPEUTIC PRODUCT EFFECT DECREASED 233 0.0052
714 BACTERIAL INFECTION 97 0.0052
715 NOCTURIA 63 0.0052
716 GOUT 93 0.0052
717 BLISTER 291 0.0052
718 FEELING HOT 317 0.0052
719 FACE OEDEMA 87 0.0052
720 ANGER 174 0.0051
721 APATHY 75 0.0051
722 FAECES DISCOLOURED 111 0.0051
723 BLOOD PRESSURE INCREASED 782 0.0051
724 WHITE BLOOD CELL COUNT DECREASED 554 0.0051
725 CARDIAC DISORDER 478 0.0051
726 RHEUMATOID ARTHRITIS 580 0.0051
727 GALLBLADDER DISORDER 91 0.0051
728 INFLAMMATION 263 0.0051
729 PRODUCT AVAILABILITY ISSUE 116 0.0051
730 LYMPHADENOPATHY 180 0.0051
731 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 278 0.0051
732 HEPATIC CIRRHOSIS 95 0.0051
733 ADVERSE REACTION 67 0.0050
734 RASH MACULO-PAPULAR 112 0.0050
735 FRACTURE 95 0.0050
736 IMMUNE SYSTEM DISORDER 66 0.0050
737 PRODUCTIVE COUGH 239 0.0050
738 CONDITION AGGRAVATED 1521 0.0050
739 CARDIAC FAILURE 399 0.0050
740 ACTIVITIES OF DAILY LIVING IMPAIRED 98 0.0049
741 ORAL HERPES 96 0.0049
742 JOINT INJURY 105 0.0049
743 ANKLE FRACTURE 76 0.0049
744 DEMENTIA 137 0.0049
745 GASTROINTESTINAL DISORDER 438 0.0049
746 CONTUSION 470 0.0049
747 PANCREATITIS 258 0.0049
748 POOR QUALITY SLEEP 105 0.0049
749 THIRST 87 0.0049
750 DERMATITIS ALLERGIC 61 0.0048
751 JOINT RANGE OF MOTION DECREASED 65 0.0048
752 CARDIOVASCULAR DISORDER 123 0.0048
753 MALAISE 2116 0.0048
754 MELAENA 106 0.0048
755 HAEMORRHAGE INTRACRANIAL 72 0.0048
756 ANOREXIA 62 0.0048
757 DYSSTASIA 140 0.0048
758 CHROMATURIA 108 0.0048
759 HEPATIC ENZYME INCREASED 325 0.0048
760 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 111 0.0048
761 WHEEZING 282 0.0048
762 EAR PAIN 92 0.0047
763 MEMORY IMPAIRMENT 650 0.0047
764 NERVOUSNESS 247 0.0047
765 LOCALISED INFECTION 114 0.0047
766 MUSCLE SPASMS 860 0.0047
767 PERITONITIS 97 0.0047
768 DIARRHOEA 3019 0.0047
769 BALANCE DISORDER 404 0.0047
770 SYNCOPE 467 0.0047
771 DYSPEPSIA 458 0.0047
772 PRODUCT ADMINISTRATION ERROR 94 0.0046
773 CRYING 169 0.0046
774 CEREBRAL INFARCTION 113 0.0046
775 FATIGUE 3596 0.0046
776 EPILEPSY 141 0.0046
777 CEREBRAL HAEMORRHAGE 165 0.0046
778 SKIN FISSURES 90 0.0046
779 CYSTITIS 146 0.0046
780 HYPERTHYROIDISM 66 0.0046
781 DYSPNOEA EXERTIONAL 171 0.0045
782 CONJUNCTIVITIS 84 0.0045
783 IRRITABILITY 271 0.0045
784 TRANSAMINASES INCREASED 100 0.0045
785 PANCREATITIS ACUTE 101 0.0045
786 DYSPHONIA 262 0.0045
787 EPISTAXIS 335 0.0045
788 DRUG INEFFECTIVE 5893 0.0045
789 HEART RATE IRREGULAR 101 0.0045
790 PHOTOPHOBIA 84 0.0045
791 JOINT SWELLING 538 0.0045
792 LIMB INJURY 121 0.0045
793 DRUG EFFECT LESS THAN EXPECTED 66 0.0044
794 DIPLOPIA 115 0.0044
795 PAIN IN EXTREMITY 1304 0.0044
796 NIGHTMARE 153 0.0044
797 PHARYNGEAL OEDEMA 68 0.0044
798 UPPER LIMB FRACTURE 88 0.0044
799 BLOOD TEST ABNORMAL 62 0.0044
800 BONE MARROW FAILURE 89 0.0044
801 EMOTIONAL DISORDER 135 0.0044
802 INTENTIONAL SELF-INJURY 88 0.0044
803 BLOOD COUNT ABNORMAL 66 0.0043
804 VERTIGO 265 0.0043
805 ARTHROPATHY 241 0.0043
806 ANGINA PECTORIS 124 0.0043
807 THROMBOSIS 348 0.0043
808 DISCOMFORT 263 0.0043
809 BRONCHITIS 318 0.0043
810 UPPER RESPIRATORY TRACT INFECTION 198 0.0043
811 LUNG DISORDER 210 0.0043
812 POLLAKIURIA 178 0.0043
813 PRODUCT PHYSICAL ISSUE 86 0.0043
814 PARAESTHESIA 668 0.0042
815 INFUSION RELATED REACTION 280 0.0042
816 CARDIAC FAILURE CONGESTIVE 339 0.0042
817 FEELING ABNORMAL 1008 0.0042
818 ORTHOSTATIC HYPOTENSION 73 0.0042
819 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 298 0.0042
820 RENAL DISORDER 195 0.0042
821 ERYTHEMA 860 0.0042
822 HYPOAESTHESIA ORAL 63 0.0042
823 BURNING SENSATION 293 0.0042
824 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 295 0.0041
825 SWELLING 387 0.0041
826 MANIA 68 0.0041
827 TREATMENT NONCOMPLIANCE 225 0.0041
828 ABDOMINAL PAIN UPPER 844 0.0041
829 MOOD SWINGS 130 0.0041
830 FLATULENCE 229 0.0040
831 RASH ERYTHEMATOUS 193 0.0040
832 HOT FLUSH 304 0.0040
833 SKIN DISCOLOURATION 185 0.0040
834 THYROID DISORDER 62 0.0040
835 PROTEINURIA 76 0.0040
836 HAEMORRHAGE 417 0.0040
837 FEELING JITTERY 76 0.0040
838 GASTROENTERITIS VIRAL 72 0.0040
839 OFF LABEL USE 3489 0.0040
840 RASH GENERALISED 103 0.0040
841 FUNGAL INFECTION 132 0.0040
842 ABDOMINAL PAIN LOWER 100 0.0040
843 PRESYNCOPE 96 0.0039
844 HYPERSENSITIVITY 732 0.0039
845 PERIPHERAL SWELLING 603 0.0039
846 DIZZINESS 1951 0.0039
847 HALLUCINATION, AUDITORY 62 0.0039
848 ARTHRALGIA 1618 0.0039
849 ISCHAEMIC STROKE 69 0.0039
850 NEPHROLITHIASIS 177 0.0039
851 PRODUCT SUBSTITUTION ISSUE 222 0.0039
852 PRURITUS GENERALISED 83 0.0038
853 MYOCARDIAL INFARCTION 669 0.0038
854 PRODUCT USE IN UNAPPROVED INDICATION 947 0.0038
855 HEAD DISCOMFORT 67 0.0038
856 SYNOVITIS 68 0.0038
857 TREATMENT FAILURE 310 0.0037
858 SINUS DISORDER 74 0.0037
859 LABORATORY TEST ABNORMAL 110 0.0037
860 ABDOMINAL DISCOMFORT 624 0.0037
861 INTERSTITIAL LUNG DISEASE 180 0.0037
862 RHINORRHOEA 240 0.0037
863 DEPRESSED MOOD 196 0.0037
864 SWOLLEN TONGUE 115 0.0037
865 THERAPEUTIC RESPONSE DECREASED 223 0.0037
866 HOSPITALISATION 563 0.0037
867 TINNITUS 168 0.0037
868 GASTRIC DISORDER 125 0.0036
869 PANCREATIC CARCINOMA 105 0.0036
870 LIP SWELLING 120 0.0036
871 LOWER LIMB FRACTURE 69 0.0036
872 INFLUENZA LIKE ILLNESS 295 0.0036
873 ILLNESS 368 0.0036
874 HERNIA 69 0.0036
875 DRUG EXPOSURE DURING PREGNANCY 121 0.0036
876 DEAFNESS 93 0.0036
877 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 166 0.0036
878 FLUID RETENTION 180 0.0035
879 EOSINOPHILIA 62 0.0035
880 SURGERY 207 0.0035
881 RASH MACULAR 123 0.0035
882 VIRAL INFECTION 117 0.0035
883 CHOKING 68 0.0035
884 MIDDLE INSOMNIA 65 0.0035
885 RASH PAPULAR 78 0.0035
886 DRUG-INDUCED LIVER INJURY 109 0.0035
887 DRUG EFFECT INCOMPLETE 126 0.0035
888 ERUCTATION 67 0.0035
889 NEOPLASM MALIGNANT 231 0.0035
890 FEMUR FRACTURE 107 0.0035
891 LIVER DISORDER 153 0.0034
892 HEADACHE 2163 0.0034
893 OROPHARYNGEAL PAIN 319 0.0034
894 AGRANULOCYTOSIS 64 0.0034
895 URTICARIA 575 0.0034
896 LOWER RESPIRATORY TRACT INFECTION 155 0.0034
897 EXTRAPYRAMIDAL DISORDER 84 0.0034
898 TRANSIENT ISCHAEMIC ATTACK 114 0.0034
899 WEIGHT INCREASED 746 0.0033
900 SWELLING FACE 216 0.0033
901 IRRITABLE BOWEL SYNDROME 71 0.0033
902 CEREBROVASCULAR ACCIDENT 560 0.0033
903 PRODUCT USE ISSUE 621 0.0033
904 CHEST DISCOMFORT 336 0.0033
905 SKIN DISORDER 109 0.0033
906 MYALGIA 553 0.0032
907 ADVERSE DRUG REACTION 291 0.0032
908 DYSGEUSIA 238 0.0032
909 RASH 1395 0.0032
910 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 641 0.0032
911 BLOOD URINE PRESENT 60 0.0032
912 CATARACT 188 0.0032
913 TASTE DISORDER 64 0.0032
914 MOOD ALTERED 86 0.0032
915 FLUSHING 317 0.0031
916 RASH PRURITIC 169 0.0031
917 ABNORMAL DREAMS 86 0.0031
918 INCORRECT DRUG ADMINISTRATION DURATION 87 0.0031
919 ASTHMA 349 0.0031
920 OSTEONECROSIS 101 0.0031
921 ADVERSE EVENT 281 0.0030
922 HERPES ZOSTER 175 0.0030
923 VISION BLURRED 412 0.0030
924 LIMB DISCOMFORT 92 0.0030
925 NASAL CONGESTION 174 0.0030
926 ERECTILE DYSFUNCTION 76 0.0030
927 INFLUENZA 330 0.0030
928 SINUSITIS 303 0.0030
929 VISUAL IMPAIRMENT 365 0.0029
930 COUGH 818 0.0029
931 PALPITATIONS 339 0.0029
932 DRUG RESISTANCE 74 0.0029
933 LUNG NEOPLASM MALIGNANT 118 0.0029
934 PRURITUS 1084 0.0028
935 LACRIMATION INCREASED 84 0.0028
936 DIABETES MELLITUS 210 0.0028
937 JOINT STIFFNESS 72 0.0027
938 AGEUSIA 68 0.0027
939 ILL-DEFINED DISORDER 163 0.0027
940 BLOOD CHOLESTEROL INCREASED 124 0.0027
941 UNDERDOSE 193 0.0026
942 THERAPY CESSATION 135 0.0026
943 GASTRIC CANCER 66 0.0026
944 DRUG DOSE OMISSION 429 0.0026
945 HYPOACUSIS 110 0.0026
946 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 445 0.0025
947 TYPE 2 DIABETES MELLITUS 83 0.0025
948 INJECTION SITE MASS 90 0.0024
949 NASOPHARYNGITIS 435 0.0024
950 PSORIATIC ARTHROPATHY 95 0.0023
951 BLINDNESS 94 0.0023
952 THROAT TIGHTNESS 61 0.0023
953 SKIN IRRITATION 103 0.0022
954 INCORRECT DOSE ADMINISTERED 505 0.0022
955 PSORIASIS 288 0.0022
956 THERAPEUTIC RESPONSE UNEXPECTED 98 0.0022
957 ACCIDENTAL EXPOSURE TO PRODUCT 225 0.0022
958 EYE PAIN 119 0.0021
959 VISUAL ACUITY REDUCED 70 0.0021
960 BONE DENSITY DECREASED 65 0.0021
961 EYE DISORDER 68 0.0021
962 OCULAR HYPERAEMIA 98 0.0021
963 COVID-19 353 0.0020
964 ECZEMA 105 0.0020
965 PRODUCT DOSE OMISSION 130 0.0020
966 MULTIPLE SCLEROSIS 95 0.0020
967 SYSTEMIC LUPUS ERYTHEMATOSUS 67 0.0019
968 THROAT IRRITATION 83 0.0018
969 SKIN EXFOLIATION 155 0.0018
970 DISEASE RECURRENCE 84 0.0018
971 BLOOD GLUCOSE DECREASED 84 0.0017
972 ALOPECIA 343 0.0017
973 MULTIPLE SCLEROSIS RELAPSE 119 0.0017
974 DEVICE LEAKAGE 75 0.0017
975 DEVICE DISLOCATION 75 0.0017
976 EYE SWELLING 63 0.0017
977 BLOOD GLUCOSE INCREASED 309 0.0016
978 DRY SKIN 213 0.0016
979 VAGINAL HAEMORRHAGE 69 0.0016
980 DEVICE ISSUE 138 0.0015
981 PROSTATE CANCER 122 0.0015
982 EXTRA DOSE ADMINISTERED 61 0.0015
983 PRODUCT DOSE OMISSION ISSUE 402 0.0014
984 NO ADVERSE EVENT 239 0.0013
985 INJECTION SITE BRUISING 100 0.0013
986 INJECTION SITE REACTION 83 0.0012
987 INJECTION SITE ERYTHEMA 140 0.0011
988 INJECTION SITE PAIN 339 0.0011
989 BREAST CANCER 100 0.0011
990 ACNE 79 0.0010
991 SKIN BURNING SENSATION 73 0.0010
992 INJECTION SITE HAEMORRHAGE 81 0.0010
993 THERAPY INTERRUPTED 70 0.0010
994 INJECTION SITE PRURITUS 62 0.0009